November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
Name that Vaccine: Which One Could Have Prevented Each of 2 Patient Scenarios?
In this current US catchup vaccination era, which immunization not yet administered could have prevented the illnesses in each situation?
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 2, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Polio Case in the US in Same NY Community that Harbored Measles Outbreak in 2018-19
The first US polio case in more than a decade was found in vaccination-poor Rockland County, NY, where the virus has now been found in wastewater.
10 Conclusions about Omicron Infection from an ID Specialist Who Just Had It
Infectious disease specialist Rodger MacArthur, MD, took a long-awaited vacation--and got COVID. He shares his conclusions about the BA.5 variant in particular.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 29, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 27, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 26, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Monkeypox Virus Questions & Answers for Family Physicians: Highlights from an AAFP Conversation
A public health expert sat down with the American Academy of Family Physicians to answer some common questions about the virus. Get the topline, here.
Monkeypox: WHO Declares Public Health Emergency of International Concern
The WHO's highest level of alert indicates the organization's belief that the now multicountry monkeypox outbreak requires a coordinated international response.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 22, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 18, 2022
Refugee Immunization Requirements: A Pop Quiz
Refresh your memory on refugee immunization recommendations with a 3-question quiz based on a patient scenario.
New MMR Vaccine Ready for Fall: How Will it Be Different?
The GSK MMR vaccine Priorix is the first new MMR shot to be available since the Merck immunization was approved in 1971. Similar? Different? Find out.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 12, 2022
Newer Omicron Subvariants Evade Neutralizing Antibodies from Vaccination and Prior Infection, Says New Research
Findings showed neutralizing antibody responses to BA.4 and BA.5 subvariants were approximately 20-fold lower than to the original WA1/2020 strain.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 30, 2022
FDA Recommends COVID-19 Booster Doses Optimized for Omicron Variant
The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 28, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 27, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 22, 2022
Merck & Co 21-valent Pneumococcal Conjugate Vaccine Ready for Phase III
The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 17, 2022
FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children 6 Months and Up
The FDA authorized emergency use of Moderna and Pfizer-BioNTech's COVID-19 vaccines for use in children as young as 6 months old.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 16, 2022